Single Family Office

Updated:

Arche Investment

Arche Investment is a Seoul-based family office deploying capital into early-stage and growth Korean technology ventures.

Arche Investment logo

Arche Investment

Arche Investment is a subsidiary of REYON Pharmaceutical, a KOSPI-listed pharmaceutical manufacturer. Founded in August 2017, the company has made 9 investments, including a Series B investment in Kasa on December 14, 2021. Arche Investment has 2 portfolio exits, with Kasa being its latest exit on March 15, 2023.

General information

Firm type

Single Family Office

Year founded

AUM

Undisclosed

Location

Region

Asia

Country

South Korea

City

Seoul

Corporate office

Seoul, South Korea

Frequently asked questions

Who runs investment decisions at Arche Investment?

The firm's principal decision-makers have not been publicly identified. Arche Investment operates as a single-family office, where investment authority typically rests with the founding family or a designated chief investment officer. Specific names have not been disclosed in regulatory filings or the firm's official communications.

How does Arche Investment source proprietary deal flow?

Arche's deal flow is understood to originate through longstanding relationships within the Korean venture ecosystem, including connections with domestic VC firms and direct founder referrals. Given its single-family structure, the firm likely benefits from legacy industrial and financial networks typical of Korean family enterprises.

Does Arche Investment participate in fund commitments or only direct deals?

The firm is structured primarily for direct equity co-investments rather than acting as a limited partner in third-party funds. No public records indicate Arche Investment has allocated capital to blind-pool fund commitments, consistent with its direct-deal posture.

What investment stages does Arche Investment typically target?

Arche Investment deploys capital from seed stage through growth rounds, with a stated focus on start-up and venture-stage opportunities. Its mandate supports both initial positions at Series A and follow-on investments into companies demonstrating commercial traction.

Where does the underlying wealth come from?

The specific wealth origin has not been publicly disclosed. Arche Investment is understood to represent the private equity allocation of a South Korean single-family group, with capital likely derived from domestic industrial or operating-business holdings.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Seoul Single Family Office profiles